ASO Author Reflections: Pancreatic Cancer Having Tumor Contact with an Aberrant Right Hepatic Artery Should be Regarded as Technically Resectable but Oncologically Borderline-Resectable

Okada K, Kawai M, Hirono S, et al. A replaced right hepatic artery adjacent to pancreatic carcinoma should be divided to obtain R0 resection in pancreaticoduodenectomy. Langenbecks Arch Surg. 2015;400:57–65.

Turrini O, Wiebke EA, Delpero JR, Viret F, Lillemoe KD, Schmidt CM. Preservation of replaced or accessory right hepatic artery during pancreaticoduodenectomy for adenocarcinoma: impact on margin status and survival. J Gastrointest Surg. 2010;14:1813–9.

Asano T, Nakamura T, Noji T, et al. Outcome of concomitant resection of the replaced right hepatic artery in pancreaticoduodenectomy without reconstruction. Langenbecks Arch Surg. 2018;403:195–202.

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Pancreatic Adenocarcinoma. version 1.2021. Available at: https://www2.tri-kobe.org/nccn/guideline/pancreas/english/pancreatic.pdf. Accessed 1 Mar 2022.

Miura Y, Ohgi K, Sugiura T, et al. Resectability status of pancreatic cancer having tumor contact with an aberrant right hepatic artery: is upfront surgery justified? Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-11624-y.